News | October 03, 2013

Radial Access Advertised to Attract Patients at Bethesda Heart Hospital

Bethesda’s interventional cardiologists offer the latest advancements in cardiac catheterization: transradial artery catheterization

Radial access cath lab bethesda transradial artery

October 3, 2013 — While 95 percent of cardiac catheterizations in the United States are done through the groin, physicians at Bethesda Heart Hospital are utilizing special training to offer patients a safer, more comfortable procedure.

Transradial artery catheterization is a less invasive endovascular technique that gives physicians access to the heart through the patient’s wrist rather than through the femoral artery in the groin. Using slightly smaller equipment through the radial artery, physicians can accomplish the same goals with fewer complications and a more satisfying patient experience.

“Patients who have had catheterizations done both ways were impressed by the comfort and ease of the radial approach,” said Michael Metzger, M.D. and interventional cardiologist. “A patient can get up from the table. They’re not spending hours lying down with compression on the groin as is required with the femoral approach.”

The femoral approach carries small but significant risks of complications, such as heavy bleeding, arterial damage, bruising or other problems. The transradial method is steadily gaining momentum because it all but eliminates these complications. Jay Midwall, M.D., interventional cardiologist, believes that in the next 10 years, between 30 and 40 percent of all cardiac catheterizations are likely to be done through the radial artery.

“It takes more time, skill and special training,” explained Midwall, adding that the radial procedure is currently prevalent in Europe and the Middle East. “As doctors in the U.S. adopted this technique, two things happened: one, patients preferred it and two, a number of studies showed it was safer with less bleeding.”

Blood flow isn’t compromised during transradial artery catheterization. Anatomical differences or medical conditions occasionally eliminate certain patients as candidates for the radial approach, but most can easily opt for this method. Regardless, both sites are prepped before a procedure begins to offer cardiologists options in case the femoral approach is needed, which is rare, according to Anil Verma, M.D. and interventional cardiologist.

The radial technique reduces the risk of bleeding and damage to blood vessels, and patients are able to stand up and walk more quickly following the procedure. These factors combine to help minimize the length of a patient’s hospital stay and to reduce costs, physicians said.

“If we have complex procedures... that require large catheters, then we have to go through the femoral artery,” Verma said, adding that these include aortic valve implant and intra-aortic balloon pumps. “But in the last 10 years, radial has caught on more and more.”

Support for the radial approach at Bethesda Heart Hospital was early and enduring, noted Metzger.

“When I chose to do transradial catheterizations four years ago, the implementation had a significant learning curve for the team,” he adds. “Now, with 40 percent of Bethesda’s procedures being performed transradially, the staff enthusiastically supports this new approach, recognizing the long-term benefits to our patients.”

For more information: www.bethesdaheart.org

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init